Slow continuous ultrafiltration in a patient with anomaly of a persistent left superior vena cavaGeorgios Aperis
Nephrology Department, General Hospital of Rhodes, Rhodes, Greece
J Ren Care 38:151-4. 2012
..Nephrologists and health care professionals must be aware of this uncommon anatomic variant. Unnecessary manipulations can lead to serious complications, such as cardiac arrhythmias, cardiac arrest and venous sinus thrombosis...
- The role of melatonin in patients with chronic kidney disease undergoing haemodialysis
Georgios Aperis
Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, Rhodes, Greece
J Ren Care 38:86-92. 2012
..Studies have shown that exogenous melatonin improves sleep-wake cycle in daytime haemodialysis patients. However, large randomised controlled trials are needed in order to establish its role in this patient population...
Anacetrapib: a new weapon against dyslipidemiaGeorgios Aperis
Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, Greece
Curr Clin Pharmacol 6:227-35. 2011
..However, longterm clinical trials are required in order to assess whether it reduces mortality in individuals at high-risk of cardiovascular disease...
- Posaconazole: a new antifungal weapon
Georgios Aperis
Department of Nephrology, General Hospital of Rhodes, Greece
Rev Recent Clin Trials 6:204-19. 2011
..Posaconazole has pharmacokinetic advantages and low side effect profile, which are very important, especially in the seriously ill population...
- The role of paricalcitol on proteinuria
Georgios Aperis
Nephrology Department, General Hospital of Rhodes, 85100 Rhodes, Greece
J Ren Care 37:80-4. 2011
..However, our study raises a question regarding why some patients do not respond to paricalcitol. Patients with proteinuria due to diabetic nephropathy seem to respond better than patients with glomerulopathy...
- Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection
Georgios Aperis
Nephrology Department, General Hospital of Rhodes, 85100 Rhodes, Greece
J Ren Care 37:25-9. 2011
..Health professionals must be aware of this uncommon effect in patients on antiretroviral treatment. Prompt initiation of CVVHF resulted in resolution of both lactic acidosis and renal failure...
- The use of pregabalin in the treatment of uraemic pruritus in haemodialysis patients
Georgios Aperis
Department of Nephrology, General Hospital of Rhodes, Rhodes 85100, Greece
J Ren Care 36:180-5. 2010
..44 ± 2.01 and 1.7 ± 1.31, respectively), p < 0.0003. Uraemic pruritus is a common and distressing symptom in patients undergoing haemodialysis. Pregabalin appears to be an effective alternative treatment...
- Corynebacterium minutissimum endocarditis: a case report and review
George Aperis
Massachusetts General Hospital, Division of Infectious Diseases, Gray Jackson Building, GRJ 516, 55 Fruit Street, Boston, MA 02114, USA
J Infect 54:e79-81. 2007
..The diagnosis was established with transesophageal echocardiogram. The patient was managed successfully with antibiotic therapy...
- Relationship between depression, clinical and biochemical parameters in patients undergoing haemodialysis
Christina Bornivelli
Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, 85100 Rhodes, Greece
J Ren Care 38:93-7. 2012
..30, p < 0.05), CRP (r = 0.38, p < 0.001) and AIS scores (r = 0.54, p < 0.0001). In conclusion, depression seems to be related to high CRP, low haemoglobin levels and sleep disorders...
- Reversal of refractory sulfasalazine-related renal failure after treatment with corticosteroids
Polichronis Alivanis
Nephrology Department, General Hospital of Rhodes, Rhodes, Greece
Clin Ther 32:1906-10. 2010
..Sulfasalazine is a combination of sulfapyridine and 5-aminosalicylic acid and is used as a first-line treatment in inflammatory bowel disease...
- Quality of life of Greek patients with end stage renal disease undergoing haemodialysis
Maria Kastrouni
Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, Rhodes 85100, Greece
J Ren Care 36:126-32. 2010
..The results from our study reflect the differences of the health care systems in various countries as well as population-related beliefs and values...
- Tolvaptan: a new therapeutic agent
Georgios Aperis
Department of Nephrology, General Hospital of Rhodes, Greece
Rev Recent Clin Trials 6:177-88. 2011
..Tolvaptan opens a new page not only in the treatment of normovolemic and hypervolemic hyponatremia but also in the treatment of acute decompensated heart failure and probably in ADPKD...
